美国食品和药物管理局关于婴儿配方"行动速度"的专家小组2025年6月:第3部分,婴儿配方营销,母乳养支持,低过敏配方和早产婴儿营养
Steven A Abrams1, J Thomas Brenna1, Roger Clemens2
1Department of Pediatrics, Dell Medical School at the University of Texas, Austin, TX, United States.
Advances in nutrition (Bethesda, Md.)
|January 21, 2026
概括
婴儿配方奶粉的营销利用了父母的恐惧,阻碍了母乳养,并造成了差距. 一个集中的FDA数据库和改进的捐赠人乳接入,可以支持基于证据的婴儿营养决策.
科学领域:
- 儿童营养学 儿童营养学
- 公共卫生政策 公共卫生政策
- 新生儿护理 新生儿护理
背景情况:
- 婴儿配方奶粉的营销策略利用了父母的焦虑,破坏了母乳养,并促进了婴儿配方奶粉的早期引入.
- 误导性配方标签对护理人员和医疗保健提供者造成混乱.
- 哺乳率的差异仍然存在,特别是在黑人和西班牙裔母亲中,这是由于结构性障碍,如不充分的育儿假和哺乳支持.
研究的目的:
- 为了突出当前婴儿配方奶粉营销和标签方面的问题.
- 为改善婴儿营养决策提出解决方案.
- 讨论母乳和捐赠母乳 (DHM) 在婴儿营养中的重要性,特别是在新生儿重症监护室 (NICU).
主要方法:
- 分析婴儿配方奶粉行业的营销做法和标签.
- 对母乳,捐赠母乳和专用配方的证据的审查.
- 检查母乳养率和促成因素的差异.
主要成果:
- 激进的配方营销违反了道德标准,并导致了差距.
- 一个集中的FDA数据库可以帮助抵制错误信息.
- 由于资金和监督问题,新生儿重症监护室对捐赠人乳 (DHM) 的获取有限.
- 专用配方奶和母乳强化剂对于特定的婴儿群体至关重要.
- 益生菌在降低早产婴儿的死亡率和发病率方面表现有前途.
结论:
- 人母奶是婴儿营养的黄金标准.
- 解决结构性障碍和改善获得母乳和DHM的机会至关重要.
- 需要一个集中的FDA数据库和明确的标签来支持基于证据的婴儿营养选择.
更多相关视频
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...


